» Articles » PMID: 37216424

Profiling Phosphoproteome Landscape in Circulating Extracellular Vesicles from Microliters of Biofluids Through Functionally Tunable Paramagnetic Separation

Overview
Specialty Chemistry
Date 2023 May 22
PMID 37216424
Authors
Affiliations
Soon will be listed here.
Abstract

Many biological processes are regulated through dynamic protein phosphorylation. Monitoring disease-relevant phosphorylation events in circulating biofluids is highly appealing but also technically challenging. We introduce here a functionally tunable material and a strategy, extracellular vesicles to phosphoproteins (EVTOP), which achieves one-pot extracellular vesicles (EVs) isolation, extraction, and digestion of EV proteins, and enrichment of phosphopeptides, with only a trace amount of starting biofluids. EVs are efficiently isolated by magnetic beads functionalized with Ti ions and a membrane-penetrating peptide, octa-arginine R , which also provides the hydrophilic surface to retain EV proteins during lysis. Subsequent on-bead digestion concurrently converts EVTOP to Ti ion-only surface for efficient enrichment of phosphopeptides for phosphoproteomic analyses. The streamlined, ultra-sensitive platform enabled us to quantify 500 unique EV phosphopeptides with only a few μL of plasma and over 1200 phosphopeptides with 100 μL of cerebrospinal fluid (CSF). We explored its clinical application of monitoring the outcome of chemotherapy of primary central nervous system lymphoma (PCNSL) patients with a small volume of CSF, presenting a powerful tool for broad clinical applications.

Citing Articles

A simplified and efficient extracellular vesicle-based proteomics strategy for early diagnosis of colorectal cancer.

Zhang J, Gao Z, Xiao W, Jin N, Zeng J, Wang F Chem Sci. 2024; .

PMID: 39421202 PMC: 11480824. DOI: 10.1039/d4sc05518g.


Predicting prognosis outcomes of primary central nervous system lymphoma with high-dose methotrexate-based chemotherapeutic treatment using lipidomics.

Zhong Y, Zhou L, Xu J, Huang H Neurooncol Adv. 2024; 6(1):vdae119.

PMID: 39119277 PMC: 11306931. DOI: 10.1093/noajnl/vdae119.

References
1.
Cesi V, Vitali R, Tanno B, Giuffrida M, Sesti F, Mancini C . Insulin-like growth factor binding protein 5: contribution to growth and differentiation of neuroblastoma cells. Ann N Y Acad Sci. 2005; 1028:59-68. DOI: 10.1196/annals.1322.007. View

2.
Duan Y, Haybaeck J, Yang Z . Therapeutic Potential of PI3K/AKT/mTOR Pathway in Gastrointestinal Stromal Tumors: Rationale and Progress. Cancers (Basel). 2020; 12(10). PMC: 7602170. DOI: 10.3390/cancers12102972. View

3.
Heitzer E, Haque I, Roberts C, Speicher M . Current and future perspectives of liquid biopsies in genomics-driven oncology. Nat Rev Genet. 2018; 20(2):71-88. DOI: 10.1038/s41576-018-0071-5. View

4.
Chen I, Xue L, Hsu C, Paez Paez J, Pan L, Andaluz H . Phosphoproteins in extracellular vesicles as candidate markers for breast cancer. Proc Natl Acad Sci U S A. 2017; 114(12):3175-3180. PMC: 5373352. DOI: 10.1073/pnas.1618088114. View

5.
Sakai H, Yokota S, Kajitani N, Yoneyama T, Kawakami K, Yasui Y . A potential contribution of tenascin-X to blood vessel formation in peripheral nerves. Neurosci Res. 2017; 124:1-7. DOI: 10.1016/j.neures.2017.06.003. View